6099184
Last Update Posted: 2025-03-04
Recruiting has ended
All Genders accepted | 18 Years + |
27 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
A prospective, randomized, single-masked study evaluating the ocular efficacy and safety of two doses of the EYP-1901 intravitreal insert compared to aflibercept
A study to evaluate Efficacy and Safety of two doses of EYP-1901 in subjects with DME
Eligibility
Relevant conditions:
Diabetic Macular Edema
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov